EGR4 and breast carcinoma: Our inability to clone the full-length EGR4 from various breast cancer cell lines, combined with the successful detection of amplicons from exon-2 (Figure 3A), did support our hypothesis for the existence of a shortened version of the protein (EGR4-S).